Search Results - "OUWEHAND, W. H."

Refine Results
  1. 1

    Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome by Barber, T. M, Bennett, A. J, Groves, C. J, Sovio, U, Ruokonen, A, Martikainen, H, Pouta, A, Hartikainen, A.-L, Elliott, P, Lindgren, C. M, Freathy, R. M, Koch, K, Ouwehand, W. H, Karpe, F, Conway, G. S, Wass, J. A. H, Järvelin, M.-R, Franks, S, McCarthy, M. I

    Published in Diabetologia (01-07-2008)
    “…Aims/hypothesis Variants in the fat-mass and obesity-associated gene (FTO) influence susceptibility to type 2 diabetes via an effect on adiposity/obesity…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation by Campbell, K., Rishi, K., Howkins, G., Gilby, D., Mushens, R., Ghevaert, C., Metcalfe, P., Ouwehand, W. H., Lucas, G.

    Published in Vox sanguinis (01-11-2007)
    “…Background  The monoclonal antibody‐specific immobilization of platelet antigens (MAIPA) assay is the cornerstone technique for the detection and…”
    Get full text
    Journal Article
  4. 4

    Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA‐5 alloantigens by Berry, J. E., Murphy, C. M., Smith, G. A., Ranasinghe, E., Finberg, R., Walton, J., Brown, J., Navarrete, C., Metcalfe, P., Ouwehand, W. H.

    Published in British journal of haematology (01-09-2000)
    “…The glycosylphosphatidylinositol‐linked platelet protein CD109 carries the biallelic alloantigen system Gov. There is limited information on the incidence of…”
    Get full text
    Journal Article
  5. 5

    Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms by Hurd, C. M., Cavanagh, G., Schuh, A., Ouwehand, W. H., Metcalfe, P.

    Published in Vox sanguinis (01-07-2002)
    “…Accurate typing of patients for platelet‐specific (human platelet) antigens (HPA) is required in several different clinical situations, and blood services need…”
    Get full text
    Journal Article
  6. 6

    Reactome – a curated knowledgebase of biological pathways: megakaryocytes and platelets by JUPE, S., AKKERMAN, J. W., SORANZO, N., OUWEHAND, W. H.

    Published in Journal of thrombosis and haemostasis (01-11-2012)
    “…The platelet field is undergoing a radical transformation from reductionist simplification to large scale integration. Following the era of simplification…”
    Get full text
    Journal Article
  7. 7

    Gain‐ and loss‐of‐function mutants confirm the importance of apical residues to the primary interaction of human glycoprotein VI with collagen by O'CONNOR, M. N., SMETHURST, P. A., FARNDALE, R. W., OUWEHAND, W. H.

    Published in Journal of thrombosis and haemostasis (01-04-2006)
    “…Background: By site‐directed mutagenesis of recombinant receptor fragments, we have previously identified residue lysine59 of the platelet collagen receptor…”
    Get full text
    Journal Article
  8. 8

    Collaborative study to establish the first international standard for quantitation of anti-HPA-1a by Allen, D., Rigsby, P., Bessos, H., Berry, J., Wilson, D., Ouwehand, W. H., Urbaniak, S., Metcalfe, P.

    Published in Vox sanguinis (01-08-2005)
    “…Background and Objectives  This report describes the production of a freeze‐dried preparation of pooled human plasma, containing immunoglobulin G (IgG)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia by Ranasinghe, E., Walton, J. D., Hurd, C. M., Saul, L., Smith, G., Campbell, K., Ouwehand, W. H.

    Published in British journal of haematology (01-04-2001)
    “…Severe fetomaternal alloimmune thrombocytopenia requires urgent treatment with compatible platelet concentrates. As prompt treatment is sometimes delayed owing…”
    Get full text
    Journal Article
  11. 11

    Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods by METCALFE, PAUL, WILLIAMSON, LORNA M., REUTELINGSPERGER, CHRIS P. M., SWANN, IAN, OUWEHAND, WILLEM H., GOODALL, ALISON H.

    Published in British journal of haematology (01-07-1997)
    “…Three different separation methods, all using centrifugation, are routinely used to prepare therapeutic platelet concentrates from human donor blood. Platelet…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time by Garner, S. F., Furnell, A., Kahan, B. C., Jones, C. I., Attwood, A., Harrison, P., Kelly, A. M., Goodall, A. H., Cardigan, R., Ouwehand, W. H.

    Published in Vox sanguinis (01-01-2017)
    “…Background and Objectives Platelet function shows significant inheritance that is at least partially genetically controlled. There is also evidence that the…”
    Get full text
    Journal Article
  14. 14

    Interlaboratory variation in the detection of clinically significant alloantibodies against human platelet alloantigens by Metcalfe, P., Allen, D., Chapman, J., Ouwehand, W. H.

    Published in British journal of haematology (01-04-1997)
    “…This report describes the results of eight workshop exercises which were designed to test the proficiency of laboratories in the detection of antibodies to…”
    Get full text
    Journal Article
  15. 15

    The discovery of genes implicated in myocardial infarction by OUWEHAND, W. H.

    Published in Journal of thrombosis and haemostasis (01-07-2009)
    “…The era of Genome‐Wide Association Studies (GWAS) commenced in 2007 with the study of the Wellcome Trust Case Control Consortium (WTCCC) which for the first…”
    Get full text
    Journal Article
  16. 16

    Platelet genomics and the risk of atherothrombosis by OUWEHAND, W. H.

    Published in Journal of thrombosis and haemostasis (01-07-2007)
    “…Platelets play a pivotal role in atherothrombosis after coronary artery plaque rupture. The extent of response of platelets to such an event varies between…”
    Get full text
    Journal Article
  17. 17

    Collaborative studies to establish the first WHO Reference Reagent for detection of human antibody against human platelet antigen-5b by Metcalfe, P., Ouwehand, W. H., Sands, D., Barrowcliffe, T. W.

    Published in Vox sanguinis (01-04-2003)
    “…Background and Objectives This report describes the production of a freeze‐dried preparation of pooled human plasma, coded 99/666, containing immunoglobulin G…”
    Get full text
    Journal Article
  18. 18

    Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain by Basu, B., Correa de Sampaio, P., Mohammed, H., Fogarasi, M., Corrie, P., Watkins, N.A., Smethurst, P.A., English, W.R., Ouwehand, W.H., Murphy, G.

    “…The membrane associated MMP, MT1-MMP, is a critical pericellular protease involved in tumour cell invasion and angiogenesis and is highly up-regulated in…”
    Get full text
    Journal Article
  19. 19

    A Human Monoclonal Antibody Specific for the Leucine-33 (P1A1, HPA-1a) Form of Platelet Glycoprotein IIIa From a V Gene Phage Display Library by Griffin, Heather M., Ouwehand, Willem H.

    Published in Blood (15-12-1995)
    “…IgG alloantibodies to polymorphic platelet glycoproteins (GPs) are known to be responsible for severe thrombocytopenia in the neonate and after transfusion…”
    Get full text
    Journal Article
  20. 20

    Human autoimmune anti‐proteinase 3 scFv from a phage display library by FINNERN, R., PEDROLLO, E., FISCH, I., WIESLANDER, J., MARKS, J. D., LOCKWOOD, C. M., OUWEHAND, W. H.

    Published in Clinical and experimental immunology (01-02-1997)
    “…This is the first study describing recombinant human antibody fragments directed to the autoantigen proteinase 3 (PR3) from an immune B cell source. Detection…”
    Get full text
    Journal Article